Evidence map›Paper›PMID 27796757›Full record

ArticleMolecular neurobiology2017

Targeted Next-Generation Sequencing Reveals Novel TTN Mutations Causing Recessive Distal Titinopathy.

Anni Evilä, Johanna Palmio, Anna Vihola, Marco Savarese, Giorgio Tasca, Sini Penttilä, Sara Lehtinen, Per Harald Jonson, Jan De Bleecker, Peter Rainer and 8 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Long-read sequencing improves diagnostic rate in neuromuscular disorders.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2023
    Review
  11. Use of animal models to understand titin physiology and pathology.Journal of cellular and molecular medicine · 2022
    Review
  12. Genotype phenotype analysis in a family carrying truncating mutations in the titin gene.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2021
    Article
  13. Genotype-phenotype correlations in recessive titinopathies.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  14. Panorama of the distal myopathies.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Titin mutations and muscle disease.Pflugers Archiv : European journal of physiology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 6 countries.

Anni EviläFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland. anni.evila@helsinki.fi.
Johanna PalmioNeuromuscular Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland.
Anna ViholaFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Marco SavareseFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Giorgio TascaInstitute of Neurology, Policlinico "A. Gemelli" Foundation University Hospital, Rome, Italy.
Sini PenttiläNeuromuscular Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland.
Sara LehtinenNeuromuscular Research Center, University of Tampere and Tampere University Hospital, Tampere, Finland.
Per Harald JonsonFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Jan De BleeckerNeuromuscular Reference Center and Neurology Department, Ghent University Hospital and St. Lucas General Hospital, University of Ghent, Ghent, Belgium.
Peter RainerDivision of Cardiology, Medical University of Graz, Graz, Austria.
Michaela Auer-GrumbachDepartment of Orthopaedics, Medical University of Vienna, Vienna, Austria.
Jean PougetNeuromuscular and ALS Reference Center, La Timone Hospital, Aix-Marseille University, FILNEMUS, Marseille, France.
Emmanuelle Salort-CampanaDepartment of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Juan J VilchezDepartment of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Nuria MuelasDepartment of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Montse OliveInstitute of Neuropathology, Department of Pathology and Neuromuscular Unit, Department of Neurology, IDIBELL-Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Peter HackmanFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Bjarne UddFolkhälsan Institute of Genetics, Biomedicum Helsinki and Department of Medical Genetics, Haartman Institute, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
University of Helsinki · FITampere University Hospital · FIHospital Universitari i Politècnic La Fe · ESAgostino Gemelli University Polyclinic · ITAix-Marseille Université · FRCentro de Investigación Biomédica en Red · ESGhent University Hospital · BEInstitut d'Investigació Biomédica de Bellvitge · ESMedical University of Graz · ATMedical University of Vienna · ATTampere University · FITelethon Institute Of Genetics And Medicine · IT

Funding

Association Française contre les Myopathies (FR) SB/CP2013-0106Austrian Science Fund FWF, P27634FWAustrian Science Fund FWF P 27634Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III PI14-00738Suomen Akatemia 138491
6 · The paper itself

Abstract

Tibial muscular dystrophy (TMD) is the first described human titinopathy. It is a mild adult-onset slowly progressive myopathy causing weakness and atrophy in the anterior lower leg muscles. TMD is caused by mutations in the last two exons, Mex5 and Mex6, of the titin gene (TTN). The first reported TMD mutations were dominant, but the Finnish founder mutation FINmaj, an 11-bp insertion/deletion in Mex6, in homozygosity caused a completely different severe early-onset limb-girdle muscular dystrophy 2J (LGMD2J). Later, we reported that not all TMD mutations cause LGMD when homozygous or compound heterozygous with truncating mutation, but some of them rather cause a more severe TMD-like distal disease. We have now performed targeted next-generation sequencing of myopathy-related genes on seven families from Albania, Bosnia, Iran, Tunisia, Belgium, and Spain with juvenile or early adult onset recessive distal myopathy. Novel mutations in TTN Mex5, Mex6 and A-band exon 340 were identified in homozygosity or compound heterozygosity with a frameshift or nonsense mutation in TTN I- or A-band region. Family members having only one of these TTN mutations were healthy. Our results add yet another entity to the list of distal myopathies: juvenile or early adult onset recessive distal titinopathy.

Indexed as

ConnectinDistal MyopathiesFemaleGene TargetingHigh-Throughput Nucleotide SequencingHumansMaleMutationPedigreeSequence Analysis, DNAYoung AdultConnectinTTN protein, humanDistal myopathyTitinTitinopathyTTN

Identifiers

PMID27796757
OpenAlexW2541494029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.